Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2500104563Phase 4Not yet recruiting
Phase 4, randomised trial in Renal colic and ureterolithiasis comparing phloroglucinol 40 mg IM, diclofenac sodium 50 mg IM and diclofenac sodium 50 mg IM + phloroglucinol 40 mg IM (3 arms). Primary endpoint: Change in visual analog scale (VAS) pain score. Planned start Jun 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2500104563.